tion angiography of both limbs demonstrated a large amount of thrombus in the distal right popliteal artery extending into the tibioperoneal trunk. Th e anterior tibial artery was occluded at the ostium. Th ere was a 99% stenosis at the tibioperoneal trunk (Figure 2 ). Manual and rheolytic thrombectomy were performed, and a 4 French Cragg-McNamara infusion catheter was placed in the distal right popliteal artery for alteplase thrombolysis. After 36 hours of intermittent thrombolysis, a large thrombus burden remained and operative embolectomy was performed in the distal popliteal and proximal tibial arteries. In addition, the remnants of the Angio-Seal closure device (string and collagen plug) were removed from the distal popliteal artery. She tolerated the procedure well and peripheral pulses returned to normal. She was discharged 2 days later.
DISCUSSION
For several decades, manual compression followed by hours of bedrest was the sole method of femoral artery puncture site hemostasis. Compression requires a trained medical professional to maintain pressure on the access site for up to 30 minutes, depending on sheath size, anticoagulation status, and several other patient and procedural characteristics. While this method is highly eff ective, it can also be extremely uncomfortable for the patient and labor intensive for the medical staff .
In the early 1990s vascular closure devices (VCDs) were introduced as an alternative to manual compression, and today a variety of VCDs are available. Th e appeal of early ambulation and enhanced patient comfort, as well as the reduction of cost associated with manual compression and in-hospital observation, has made the use of VCDs commonplace. It is estimated that over 1 million VCDs are used yearly in the United States (1) .
Despite widespread use, the superiority of VCDs over manual compression in terms of complications has not been defi nitively proven. Th ere are no large randomized clinical trials comparing complication rates of manual compression to those of VCDs. Several large metaanalyses and registries have yielded confl icting data regarding superiority (2-9). Tavris et al reviewed 166,680 patients from the American College of CardiologyNational Cardiovascular Data Registry database who underwent cardiac catheterization in 2001. In this cohort, 53,655 patients received a VCD to obtain hemostasis, while 113,025 patients received manual compression. Th e risk of experiencing any vascular complication was 1.1% in the VCD group and 1.7% in the manual compression group (P < 0.001) (9) . In 2004, Nikolsky et al conducted a metaanalysis of 30 studies involving 37,066 patients undergoing cardiac catheterization. In this study vascular complication rates were higher in the patients who received a VCD (odds ratio 1.34; 95% confi dence interval 1.01-1.79) (6) .
Complications related to VCDs may be broadly classifi ed into three categories: hemorrhagic, obstructive, and infective (10) . Th e most feared complication of VCDs is limb ischemia. Th is can occur as a result of embolization, thrombosis, or occlusion from the intravascular component of the device (11) . Several studies have reported the incidence of lower limb ischemic complications following Angio-Seal use (12) (13) (14) (15) (16) (13) . One possible explanation for the wide variation in ischemic complication rates may be operator experience. Balzer et al clearly demonstrated that VCD delivery success rates increased as the operator's experience and familiarity with the device increased (17) .
Limb ischemic symptoms can present acutely in the minutes after device deployment, but may also have a subacute presentation with claudication in the days or weeks following the procedure (18) . Endovascular approaches to treat limb ische mia caused by VCDs have been described, but most authors recommend direct surgical cutdown, retrieval of the device, and defi nitive arterial repair, most often with venous patch plasty (10). Steinkamp et al reported on their experience using excimer laser and balloon angioplasty in 13 patients with lower limb ischemic symptoms as a result of either vessel occlusion or stenosis related to an Angio-Seal device. Four of the 13 patients had complete vessel occlusion while the remaining 9 had lowerextremity vessel stenosis. All patients were successfully treated and experienced increased walking distance and an improved ankle-brachial index immediately following the procedure and at 3-and 6-month follow-up (19) .
Although endovascular or open surgical treatment of limb ischemia resulting from VCDs can be limb sparing, it can be associated with additional signifi cant morbidity. Wille et al described several cases of limb ischemia resulting from Angio-Seal deployment (18) . One patient required a four-compartment fasciotomy of the lower leg to treat reperfusion-induced compartment syndrome. In addition, the lateral skin defect needed split skin grafting 6 weeks after the procedure. A second patient experienced postoperative groin infection that required debridement, sartorius muscle transposition, and a prolonged course of intravenous antibiotics. Fortunately, our patient had no postoperative sequelae.
While VCDs may reduce the time to ambulation and discharge, enhance patient comfort, improve staff effi ciency, and Critical lower limb ischemia from an embolized Angio-Seal closure devicereduce costly in-hospital monitoring, they can expose patients to additional risks, which can be life and limb threatening. Physicians, nurses, and ancillary staff must be aware of such risks, recognize early signs of potential problems, and act expeditiously.
